Literature DB >> 22630083

BMPS and liver: more questions than answers.

Blanca Herrera1, Aranzazu Sánchez, Isabel Fabregat.   

Abstract

Bone morphogenetic proteins (BMPs) belong to the TGF-β superfamily and were first discovered as potent bone homeostasis regulators for their ability to induce endochondral bone formation, ectopic bone formation and fracture repair. A preeminent role of BMP signaling in developmental control of cell type specification, differentiation and organogenesis is also well established. More recently, a role for BMPs in adult tissue homeostasis has started being revealed. Thus, new studies show that BMPs regulate many cellular processes such as proliferation, apoptosis, differentiation and migration in many tissues and organs. As a consequence, dysregulation of BMP activity can have pathological consequences, and there is mounting evidence for the involvement of BMPs in different human diseases. In this review, we have focused on summarizing the present knowledge on the relevance of BMPs in liver physiology and pathophysiology, from the well-recognized role in liver development to the emerging contribution to the function and dysfunction of the adult liver. While no doubts seem to rise about the regulatory activities of BMPs on metabolic pathways in the liver, potential pro- and anti-fibrogenic and tumorigenic actions will likely be a matter of debate during coming years. Collectively, the work here presented provides the basis to consider BMPs as potential targets of intervention in liver diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22630083     DOI: 10.2174/138161212802430503

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  New insights into BMP9 signaling in liver diseases.

Authors:  Qian-Qian Jiang; Bei-Bei Liu; Ke-Shu Xu
Journal:  Mol Cell Biochem       Date:  2021-05-21       Impact factor: 3.396

2.  Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.

Authors:  Carlos Ernesto Fernández-García; Stephania C Isaza; Esther Rey; Patricia Marañón; Rocío Gallego-Durán; Rocío Montero-Vallejo; Javier Rodríguez de Cía; Javier Ampuero; Manuel Romero-Gómez; Carmelo García-Monzón; Águeda González-Rodríguez
Journal:  Biomark Res       Date:  2022-05-25

3.  TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.

Authors:  S M Morris; K T Carter; J Y Baek; A Koszarek; M M Yeh; S E Knoblaugh; W M Grady
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

Review 4.  Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.

Authors:  Blanca Herrera; Steven Dooley; Katja Breitkopf-Heinlein
Journal:  Int J Mol Sci       Date:  2014-03-25       Impact factor: 5.923

Review 5.  Elastin in the Liver.

Authors:  Jiří Kanta
Journal:  Front Physiol       Date:  2016-10-25       Impact factor: 4.566

6.  Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway.

Authors:  Juncheng Guo; Min Guo; Jinfang Zheng
Journal:  Cancer Manag Res       Date:  2021-01-27       Impact factor: 3.989

7.  BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.

Authors:  Blanca Herrera; María García-Álvaro; Silvia Cruz; Peter Walsh; Margarita Fernández; Cesáreo Roncero; Isabel Fabregat; Aránzazu Sánchez; Gareth J Inman
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

8.  BMP9-Induced Survival Effect in Liver Tumor Cells Requires p38MAPK Activation.

Authors:  María García-Álvaro; Annalisa Addante; Cesáreo Roncero; Margarita Fernández; Isabel Fabregat; Aránzazu Sánchez; Blanca Herrera
Journal:  Int J Mol Sci       Date:  2015-08-28       Impact factor: 5.923

9.  A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival.

Authors:  Annalisa Addante; Cesáreo Roncero; Nerea Lazcanoiturburu; Rebeca Méndez; Laura Almalé; María García-Álvaro; Peter Ten Dijke; Isabel Fabregat; Blanca Herrera; Aránzazu Sánchez
Journal:  Cells       Date:  2020-03-19       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.